QScript: regulatory considerations for dentists
This lecture is designed for Dentists.
Course overview
Update for dentists about the operation of the Medicines and Poisons Act 2019 and Medicines and Poisons (Medicines) Regulation 2021 and the requirements for the use of QScript in dental practice.
- Legislative and regulatory obligations (QScript and Monitored Medicines Standard)
- QScript notifications
- Clinical and regulatory issues
Â
Learning Objectives
Key, measurable learnings participants will gain upon completion of this course:
• Understanding of current legislative and regulatory requirements in regard to QScript and Monitored Medicines Standard
• Understanding of meaning of notifications in QScript
• Brief discussion of other regulatory issues
• Where to find supporting information and materials for QScript and other medicines legislative requirements.
Â
Presenter biography
Dr Bill Loveday
Dr Bill Loveday is Director of Monitored Medicines Unit (MMU) at Queensland Health. MMU manages and administers QScript, Queensland’s real-time prescription monitoring program, and along with other Queensland Health units undertakes regulatory compliance activities in regards to the Medicines and Poisons Act 2019 and Medicines and Poisons (Medicines Regulation) 2021 in relation to certain health practitioners use of scheduled medicines. Bill is a registered psychologist and undertook his doctoral research into the study of examining doctor shopping behaviour for prescription opioids in the Queensland population and he is a perpetual student of contemporary regulatory practice.
Â
Â
Event Pricing
ADA Member Dentist - FREE
Non-Member Dentist - $55
CPD Points
1 Non-Scientific hour
By registering for this course, you agree to the events terms and conditions outlined on the ADAQ website.Â